Life sciences company Revvity (NYSE: RVTY) will be announcing earnings results this Monday before market open. Here’s what you need to know.
Revvity met analysts’ revenue expectations last quarter, reporting revenues of $698.9 million, up 2.2% year on year. It was a satisfactory quarter for the company, with a decent beat of analysts’ full-year EPS guidance estimates but organic revenue in line with analysts’ estimates.
Is Revvity a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting Revvity’s revenue to grow 4.7% year on year to $763.5 million, in line with the 4.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.58 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Revvity has only missed Wall Street’s revenue estimates once over the last two years, exceeding top-line expectations by 0.8% on average.
Looking at Revvity’s peers in the life sciences tools & services segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Thermo Fisher delivered year-on-year revenue growth of 7.2%, beating analysts’ expectations by 2.1%, and Danaher reported revenues up 4.6%, in line with consensus estimates. Thermo Fisher traded down 4.8% following the results while Danaher was also down 6.8%.
Read our full analysis of Thermo Fisher’s results here and Danaher’s results here.
Investors in the life sciences tools & services segment have had steady hands going into earnings, with share prices up 1.1% on average over the last month. Revvity is up 10.9% during the same time and is heading into earnings with an average analyst price target of $116.19 (compared to the current share price of $108.79).
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
